Literature DB >> 23380747

Relationship of vitamin D monitoring and status to bladder cancer survival in veterans.

Alan N Peiris1, Beth A Bailey, Todd Manning.   

Abstract

OBJECTIVES: Veterans of the armed forces, like most population groups, have a high prevalence of vitamin D deficiency, which may be associated with adverse outcomes in several types of cancer. Ultraviolet irradiation is inversely linked with the risk of bladder cancer, presumably through enhanced vitamin D synthesis. We hypothesized that variations in vitamin D status and monitoring predict adverse outcomes in bladder cancer among veterans.
METHODS: A retrospective analysis of data in the Veterans Integrated Service Network-9 (southeastern United States) was performed for patients diagnosed between October 1, 1999 and February 29, 2008. Age, tobacco exposure, body mass index, and latitude and seasonality of sampling were included as variables in addition to serum vitamin 25(OH)D levels.
RESULTS: Monitoring of vitamin D and vitamin D levels and status were closely linked to survival in bladder cancer. Both the chances of survival and longevity improved with enhanced vitamin D status and monitoring. Veterans with bladder cancer had better outcomes if the initial vitamin D level was higher and had more monitoring of the vitamin. Initial vitamin D levels were more strongly related to outcomes than follow-up levels. The link between vitamin D and outcomes remained after adjusting for background variables such as age, body mass index, latitude, seasonality, and tobacco exposure.
CONCLUSIONS: Findings suggest that adequate vitamin D levels early in the course of the disease provide the best opportunity to improve outcomes. Ensuring that veterans with bladder cancer have adequate vitamin D reserves with appropriate monitoring may play a role in improving outcomes in bladder cancer.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23380747     DOI: 10.1097/SMJ.0b013e3182824d00

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  5 in total

Review 1.  Dietary factors associated with bladder cancer.

Authors:  Chandrika Piyathilake
Journal:  Investig Clin Urol       Date:  2016-06-10

2.  Vitamin D3 Intake Dose and Common Cancer: A Population-Based Case Control Study in a Chinese Population.

Authors:  Henry Wc Leung; Chih-Hsin Muo; Chung-Feng Liu; Agnes Lf Chan
Journal:  J Cancer       Date:  2016-10-21       Impact factor: 4.207

Review 3.  The impact of vitamin D pathway genetic variation and circulating 25-hydroxyvitamin D on cancer outcome: systematic review and meta-analysis.

Authors:  P G Vaughan-Shaw; F O'Sullivan; S M Farrington; E Theodoratou; H Campbell; M G Dunlop; L Zgaga
Journal:  Br J Cancer       Date:  2017-03-16       Impact factor: 7.640

4.  Vitamin D3 enhances the response to cisplatin in bladder cancer through VDR and TAp73 signaling crosstalk.

Authors:  Brittany L Bunch; Yingyu Ma; Kristopher Attwood; Lauren Amable; Wei Luo; Carl Morrison; Khurshid A Guru; Anna Woloszynska-Read; Pamela A Hershberger; Donald L Trump; Candace S Johnson
Journal:  Cancer Med       Date:  2019-04-10       Impact factor: 4.452

5.  Prediagnostic Serum 25-Hydroxyvitamin D and Mortality Among Bladder Cancer Patients in the Janus Serum Bank Cohort.

Authors:  Helga H Hektoen; Randi E Gislefoss; Jo S Stenehjem; Hilde Langseth; Karol Axcrona; Alison M Mondul; Trude E Robsahm; Bettina K Andreassen
Journal:  Clin Epidemiol       Date:  2021-09-14       Impact factor: 4.790

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.